drugset / Trial / NCT06455293
Psilocybin Therapy for Depression in Parkinson's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to understand whether people with Parkinson's Disease and depression have improvement in their symptoms after psilocybin therapy.
Timeline
- Start
- 2024-08-19
- Primary completion
- 2027-06
- Completion
- 2028-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pimavanserin | Small molecule | — | — |
| Subject | Psilocybin | Other / unclassified | — | Oral |